Patent ID: 9623145
Date: 2017-04-18
CPC Classifications: A61L,A61P,B33Y,C08L

Claim:
1. A curable composition comprising: (a) 60 wt. % to 95 wt. % of one or more vinyl ester monomers, wherein said one or more vinyl ester monomers are selected from: (i) a vinyl ester monomer having a formula of wherein n is an integer from 1 to 12; (ii) monomers selected from diethylene glycol bis[O—(O′-vinylmaleinoyl)-polylactate]) (DVMPL); ω,ω′-3,6,9-trioxaundecanedioic acid divinyl ester (TUVE); polyglutamic acid; polyaspartic acid; hyaluronic acid; polylactic acid; polyglycolic acid; and poly(lactide-co-glycolide); (iii) or combinations thereof; (b) 0.1 to 40 wt. % of one or more multifunctional thiols selected from the group consisting of ethoxylated pentaerythritol tetra-(3-mercaptopropionate); trimethylpropane tri(3-mercapto-propionate); ethoxylated trimethylpropane tri(3-mercapto-propionate); glycol dimercaptoacetate; trimethylolpropane trimercaptoacetate; pentaerythritol tetramercaptoacetate; ethoxylated trimethylolpropane tri-3-mercaptopropionate; and ethoxylated trimethylolpropane tri-3-mercaptopropionate; polypropylene glycol (3-mercaptopropionate); polypropylene glycol (3-mercaptopropionate); and (c) 0 to 10 wt. % of a biocompatible polymerization initiator.